Biomerica (BMRA) Net Income towards Common Stockholders (2010 - 2026)

Biomerica has disclosed Net Income towards Common Stockholders across 17 years of filings, most recently posting -$1.3 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$1.3 million, down 12.81% year-over-year; the trailing twelve-month figure through Feb 2026 was -$4.2 million (up 12.42% YoY), and the FY2025 annual result was -$5.0 million, up 15.63% from the prior year.
• Net Income towards Common Stockholders came in at -$1.3 million for Q1 2026 at Biomerica, up from -$1.3 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $2000.0 in Q3 2025 to a low of -$2.1 million in Q3 2022.
• The 5-year median for Net Income towards Common Stockholders is -$1.3 million (2024), against an average of -$1.3 million.
• Across the five-year window, Net Income towards Common Stockholders tumbled 1483.98% in 2023 and jumped 100.15% in 2025, its largest moves.
• Biomerica's Net Income towards Common Stockholders stood at -$1.6 million in 2022, then gained by 7.32% to -$1.5 million in 2023, then surged by 36.96% to -$950000.0 in 2024, then plunged by 38.95% to -$1.3 million in 2025, then rose by 0.61% to -$1.3 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$1.3 million (Q1 2026), -$1.3 million (Q4 2025), and $2000.0 (Q3 2025), per Business Quant data.